Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure
Labiotech.eu (blog) Imcyse, a Belgian biotech spun out from the Katholieke Universiteit Leuven in 2010, just announced it has received approval from Belgian and British regulatory authorities to launch a Phase Ib trial in patients with type 1 diabetes. The study is backed ... |
Social Plugin